March 16, 2026
Özlem Cosar
Share
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis
March 9, 2026
Semaglutide Improves Histology in MASH: Phase 3 ESSENCE Trial
January 20, 2026
Can fecal microbiota transplant be used for hepatic encephalopathy ? The THEMATIC trial
November 17, 2025